Search research articles
Contact Us
Filters
Showing results (31-40 of 129) with videos related to
Page
of 13
Sort By:
Gut
|
December 15, 2022
Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease
Tracey G Simon, Bjorn Roelstraete, Naim Alkhouri, et al.
Gastroenterology
|
August 10, 2020
Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis
Ashwini Arvind, Stephanie A Osganian, Julia A Sjoquist, et al.
Cardiovascular Diabetology
|
December 14, 2023
Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study
Tracey G Simon, Fahim Ebrahimi, Bjorn Roelstraete, et al.
Journal of Hepatology
|
July 21, 2021
Maternal obesity increases the risk and severity of NAFLD in offspring
Hannes Hagström, Tracey G Simon, Bjorn Roelstraete, et al.
Hepatology (Baltimore, Md.)
|
April 3, 2021
Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Tracey G Simon, Bjorn Roelstraete, Rajani Sharma, et al.
European Journal of Radiology
|
July 28, 2012
Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation
Tracey G Simon, Michael D Beland, Jason T Machan, et al.
Journal of the American Heart Association
|
January 10, 2023
Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
Tracey G Simon, Sebastian Schneeweiss, Daniel E Singer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 1, 2019
The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study
Tracey G Simon, Xuan Deng, Ching-Ti Liu, et al.
Alimentary Pharmacology & Therapeutics
|
February 12, 2020
Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease
Jacqueline B Henson, Tracey G Simon, Alyson Kaplan, et al.
BMC Infectious Diseases
|
November 13, 2015
Changes in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES
Adeel A Butt, Peng Yan, Tracey G Simon, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 129) with videos related to
Sort By:
Page
of 13
Gut
|
December 15, 2022
Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease
Tracey G Simon, Bjorn Roelstraete, Naim Alkhouri, et al.
Gastroenterology
|
August 10, 2020
Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis
Ashwini Arvind, Stephanie A Osganian, Julia A Sjoquist, et al.
Cardiovascular Diabetology
|
December 14, 2023
Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study
Tracey G Simon, Fahim Ebrahimi, Bjorn Roelstraete, et al.
Journal of Hepatology
|
July 21, 2021
Maternal obesity increases the risk and severity of NAFLD in offspring
Hannes Hagström, Tracey G Simon, Bjorn Roelstraete, et al.
Hepatology (Baltimore, Md.)
|
April 3, 2021
Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Tracey G Simon, Bjorn Roelstraete, Rajani Sharma, et al.
European Journal of Radiology
|
July 28, 2012
Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation
Tracey G Simon, Michael D Beland, Jason T Machan, et al.
Journal of the American Heart Association
|
January 10, 2023
Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
Tracey G Simon, Sebastian Schneeweiss, Daniel E Singer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 1, 2019
The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study
Tracey G Simon, Xuan Deng, Ching-Ti Liu, et al.
Alimentary Pharmacology & Therapeutics
|
February 12, 2020
Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease
Jacqueline B Henson, Tracey G Simon, Alyson Kaplan, et al.
BMC Infectious Diseases
|
November 13, 2015
Changes in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES
Adeel A Butt, Peng Yan, Tracey G Simon, et al.
Page
of 13